In utero exposure to persistent organic pollutants (POPs) can result in thyroid function disorder, leading to concerns about their impact on fetal and neonatal development. The associations between placental levels of various POPs and thyroid hormones (THs) were investigated. In a prospective Danish study initially established for assessing congenital cryptorchidism, 58 placenta samples were collected from mothers of boys born with (n = 28) and without (n = 30) cryptorchidism. The concentrations of polybrominated diphenyl ethers (PBDEs), polychlorinated biphenyls (PCBs), polychlorinated dibenzo-p-dioxins/furans (PCDD/Fs), organotin chemicals (OTCs), organochlorine pesticides (OCPs), T 4 , T 3 , and rT 3 were measured. The associations between placental THs and various POPs were analyzed using multiple linear regression. Five PBDEs, 35 PCBs, 14 PCDD/Fs, 3 OTCs, 25 OCPs, T 4 , T 3 , and rT 3 were measured. No correlation between THs and the odds of cryptorchidism was found. Several POPs were significantly associated with THs: (1) T 4 was inversely associated with BDEs 99, 100, SPBDE, and 2378-TeCDD, and positively associated with 1234678-HpCDF; (2) T 3 was positively associated with 2378-TeCDF and 12378-PeCDF; and (3) rT 3 was positively associated with PCB 81, 12378-PeCDF, and 234678-HxCDF, and inversely associated with tributyltin, SOTC, and methoxychlor. These results revealed that POP exposures were associated with TH levels in placenta, which may be a possible mechanism for the impacts of POP exposures on children's growth and development. This study provides new insight into the complexity of thyroid-disrupting properties of POPs. More research is needed to elucidate the biological consequences of POP exposures. (Endocrinology 159: 3473-3481, 2018) T hyroid hormones (THs) are a group of tyrosine-based hormones that act on cells of almost all tissues and therefore are involved in important physiological processes during a life span (1, 2). The human thyroid system is susceptible to disruption by endogenous (e.g., autoantibodies) or exogenous (e.g., iodine) factors via interference with the sodium-iodide symporter, TH metabolism, receptors, and TH transport (3). Consequently, there are concerns regarding the chronic background exposure to persistent organic pollutants (POPs), which
have been shown or are suspected to have thyroiddisrupting properties.
POPs have been used in a wide variety of commercial and industrial applications over the past few decades. They are also released from traffic and incineration. Common POPs include polybrominated diphenyl ethers (PBDEs), polychlorinated biphenyls (PCBs), polychlorinated dibenzo-p-dioxins and furans (PCDD/Fs), organotin chemicals (OTCs), and organochlorine pesticides (OCPs), among others. Diet, inhalation, and inadvertent dust ingestion are possible exposure pathways to these chemicals for humans (4, 5) . Although there are international agreements intended to reduce or cease POP production, POPs are still widely detectable in the biotic and abiotic environment because of their high lipophilicity and resistance to degradation (6) . POPs have been detected in human samples, such as blood and breast milk, from all over the world (7) .
POPs are transferred to the fetus across the placenta during pregnancy (8) (9) (10) . Passive diffusion and/or active uptake are involved in this process. The placenta can also act as a repository for these lipophilic chemicals. Thus, there is a risk for disruption of the fetal development because POPs in placenta may affect the amount of THs delivered to the fetus. This is particularly important during early pregnancy when the fetus depends solely on maternally derived THs (11) . Even subtle changes in maternal TH transfer can lead to various detrimental outcomes such as miscarriage, intrauterine growth retardation, hypertensive disorders, preterm delivery, and a decreased child IQ (12) .
Disruption of TH levels after POP exposure has been observed in vitro and in animal studies (13, 14) . Human epidemiological studies have also found associations between POP exposures and TH disruption in the general population (15, 16) [e.g., in e-waste recycling workers (17, 18) , pregnant women (19) (20) (21) (22) and infants (22) ]. Recent studies suggested that prenatal exposure to POPs may interfere with the neurologic development of the children (23) , as well as their motor, cognitive, and behavioral performance (24, 25) . However, all these studies were conducted with serum, plasma, or breast milk samples. To our knowledge, only one study has been performed in placenta on the associations of THs with PBDEs (26) , and no research data on such an association are available on PCBs, PCDD/Fs, OTCs, and OCPs. It is therefore worthwhile to conduct a comprehensive analysis by including as many POPs as possible to have a complete overview of the association between in utero POP exposures and THs.
The potential thyroid-disrupting effects of POPs in background exposed populations are of interest because THs act at extremely low serum concentrations (free concentration range, 8 to 30 pg/mL), and POPs can mimic or inhibit the response of the hormones at low doses (e.g., the low dose cutoff of BDE 99 is 0.3 mg/kg/d) (27, 28) . The purpose of this study was to investigate the possible association of background exposures of POPs (specifically, PBDEs, PCBs, PCDD/Fs, OTCs, and OCPs) with placental levels of THs (T 4 , T 3 , and rT 3 ) in a Danish population that gave birth to boys with and without cryptorchidism.
Materials and Methods

Study population
The placenta samples were obtained from a joint prospective, longitudinal birth cohort study performed from 1997 to 2001 at the National University Hospital (Rigshospitalet, Hvidovre Hospital), Copenhagen, Denmark. Details of the standardized recruitment strategy, inclusion criteria, participation rate, and clinical examination techniques have been reported (29, 30) . Placentas were collected at birth by the midwives and kept frozen in polyethylene bags at 220°C. Upon analysis, placentas were defrosted, mechanically homogenized, and aliquoted into 20-mL glass tubes. Fifty-eight placenta samples were derived from mothers of healthy boys (n = 30) and mothers of boys with cryptorchidism (n = 28) at birth in a nested case-control design. The number of included placenta samples was determined by funding. The demographic variables of both groups are shown in an online repository (31) .
This study followed the Declaration of Helsinki, version 2004. The Danish ethics committee (approval no. KF01-030/ 97) and the Danish Data Protection Agency (approval no. 1997-1200-074) approved the study. Informed written consent was obtained from the parents of each boy.
Data collection
We determined the total concentrations of T 4 , T 3 , and rT 3 in placenta samples. Detailed information about the hormones, sample preparation, extraction procedure, analytical method, reagents, and instrumentation has been described (32) . Briefly, a 100-mg placenta sample was extracted using solid/ liquid extraction, liquid/liquid extraction, and weak cationexchangers (Bond Elut Plexa PCX) solid-phase extraction cleanup. Finally, the compounds were quantified by ultraperformance liquid chromatography quadrupole time-of-flight mass spectrometry (UPLC-Q-TOF-MS). An antioxidant solution consisting of 10 mg/mL citric acid monohydrate, (+)-Lascorbic acid, and R,R-dithiothreitol was added to reduce the deiodination of THs. Isotope labeled analogs of THs (i.e., 13 C 6 -T 3 , 13 C 6 -rT 3 , and 13 C 6 -T 2 ) were spiked before extraction to assess the potential deiodination. The results confirmed that no conversion of THs happened during the analytical process. The method quantification limits of T 4 , T 3 , and rT 3 were 0.7, 0.3, and 0.2 ng/g, respectively. The procedural recoveries for the hormones were 81.0% to 105%, with a coefficient of variation (CV) of 0.5% to 6.2%. The intraday CVs and interday CVs were 0.5% to 4.19% and 1.19% to 6.38%, respectively (32) .
PBDEs, PCBs, PCDD/Fs, OTCs, and OCPs were targeted for analysis in this study. The methods for the sample cleanup and quantification of the compounds have been described in detail elsewhere (30, (33) (34) (35) . The method for lipid measurement has been described (30) . A brief description of the methods is given in an online repository (31) . In addition, we included the World Health Organization toxic equivalent (WHO-TEQ) values of PCDD/Fs and PCBs. This parameter was developed to measure the combined toxicity of dioxin and dioxin-like compounds through the toxic equivalency factors, which assesses the toxicity of each congener relative to 2378-TeCDD (36) .
Statistics
We determined the potential effects of POPs on thyroid status for congeners with a detection frequency .50%, except for dibutyltin, tributyltin (TBT), and triphenyltin, which were detected in 38%, 41%, and 34% of the samples, respectively. We included OTCs regardless of detection frequency because of the growing concerns about environmental effects as well as a lack of studies on the TH effects of these chemicals. Concentrations below the limit of quantification (LOQ) were replaced by the LOQ divided by the square root of 2. The distributions of POP values were much closer to log-normal than normal and were thus log 10 -transformed. T 4 , T 3 , and rT 3 were normally distributed and not transformed. Normality was confirmed using the Kolmogorov-Smirnov test. We used Spearman rank correlations to evaluate the interrelationship of POP congeners and ANOVA to examine associations between demographic characteristics and POP concentrations. Adjusted and unadjusted logistic regressions were used to compare placental TH concentrations in cases with cryptorchidism and in control subjects. No differences were observed; therefore, cases and control subjects were pooled for analysis of the association between POPs and THs by multiple linear regression for individual POP congeners and the sums.
Potential confounders considered for inclusion in the models were parameters known to influence THs and included the following: maternal age, gestational age, parity (nulliparous vs one or more live birth), maternal prepregnant body mass index (BMI), smoking during pregnancy (yes vs no), mode of delivery (three categories: vaginal delivery, vacuum extraction, and cesarean delivery), birth weight, and birth length. Final models included variables that were loosely associated with the THs (P , 0.20) in bivariate analyses.
All statistical analyses were conducted using SAS (version 9.4; SAS Institute Inc., Cary, NC) and R (version 3.4.2; R Foundation for Statistical Computing, Vienna, Austria). A P-value , 0.05 was considered significant, and P , 0.10 was considered as a tendency of association. Table 1 summarizes the characteristics of all the participating women and newborns. The mean 6 SD age of women was 30.4 6 3.5 years. Among them, 19 (32.8%) were .30 years old; 47 (81%) had a BMI value of ,25 kg/m 2 ; 39 (67.2%) did not smoke; 49 (84.5%) had a normal delivery; and 35 (60.3%) were nullipara. A total of 54 babies (93.1%) were delivered at over 37 weeks of gestation (full term). The demographic parameters did not differ significantly between the cryptorchid and control groups except for gestational age, which was lower in boys with cryptorchidism (P , 0.06) (31).
Results
As shown in Table 1 , the mean concentration of T 4 was 37.6 ng/g fresh weight (fw) (range, 16.3 to 68.3 ng/g fw). The mean concentration of rT 3 was 4.57 ng/g fw (range, 1.82 to 9.03 ng/g fw). The mean level of T 3 was 0.85 ng/g fw (range, 0 to 2.34 ng/g fw). TH levels were similar across age, BMI, parity, mode of delivery, and birth length of the infants. However, T 4 placental level was lower in mothers that smoke (P , 0.029). T 4 concentration increased with increasing gestational age (P , 0.004) and birth weight (P , 0.004). However, T 3 and rT 3 placental levels were not correlated with any of the studied characteristics. Placental concentrations of THs did not significantly differ between boys with cryptorchidism and the control subjects ( Table 2) .
The concentrations of a total of 82 POPs and their sums, as well as the WHO-TEQ values of PCDD/Fs and PCBs, in placenta are shown in an online repository (31) . The LOQ values were as follows: 0.004 to 0.14 ng/g lipid for PBDEs (33); 0.17 pg/g lipid for non-ortho-PCBs; 0.01 ng/g lipid for mono-and di-ortho-PCBs; 0.12 to 0.25 pg/g lipid for tetra-to hepta-chlorinated PCDD/Fs; 1.2 pg/g lipid for octa-chlorinated PCDD/Fs (37); 0.1 ng/g fw for dibutyltin; and 0.02 ng/g fw for TBT and triphenyltin (34). The limit of detection values of the OCPs ranged from 0.01 ng/g lipid to 1.24 ng/g lipid (30) .
As shown in Table 3 and an online repository (31), T 4 concentration was inversely significantly associated with the sum of five PBDEs (b = 219.0; 95% CI, 235.7 to 22.37; P , 0.026) as well as with BDE 99 (b = 220.2; 95% CI, 235.2 to 25.29; P , 0.009) and BDE 100 (b = 213.5; 95% CI, 226.8 to 20.22; P , 0.047), with a tendency toward significance for BDE 47 concentration (b = 214.1; 95% CI, 228.5 to 0.24; P , 0.054). T 3 and rT 3 concentrations were not significantly associated with any of the PBDE congeners.
T 4 concentration had negative tendencies toward significance with levels of PCB 99 (b = 215.9; 95% CI, 233.4 to 1.65; P , 0.075), PCB 118 (b = 213.4; 95% CI, 229.0 to 2.27; P , 0.092), and PCB 167 (b = 211.7; 95% CI, 225.7 to 2.29; P , 0.099). No statistically significant associations between concentrations of T 3 and PCB congeners were observed. rT 3 to 21.51; P , 0.001) and the sum of OTCs (b = 24.96; 95% CI, 27.78 to 22.14; P , 0.001), whereas none of the OTCs had a significant association with T 4 or T 3 levels. b-hexachlorocyclohexane (b-HCH) had negative tendencies toward significance with concentrations of T 4 (b = 213.9; 95% CI, 228.7 to 0.90; P , 0.065), T 3 (b = 20.68; 95% CI, 21.44 to 0.09; P , 0.081), and rT 3 (b = 22.06; 95% CI, 24.50 to 0.38; P , 0.097), although none of them was statistically significant. Methoxychlor was inversely significantly associated with rT 3 concentration (b = 22.30; 95% CI, 23.88 to 20.72; P , 0.005).
Discussion
We measured placental T 4 , T 3 and rT 3 concentrations by an UPLC-Q-TOF-MS method, which offers good sensitivity and specificity (32) . The TH levels reported here corresponded well with previous findings in human placenta (26, 38) . Placental levels of some contaminants might be representative of fetal exposures due to the placental transfer of POPs during gestation (39) .
We observed correlations between T 4 levels and gestational age, maternal smoking, and birth weight, which were in accordance with findings of previous studies (40) (41) (42) (43) . These variables, therefore, were included in the statistical analysis as cofounders. Other researchers have also found associations of THs with mode of delivery (40) , alcohol consumption (44) , and maternal BMI (45) .
A previous review suggested that THs may play a role in the development and function of the testis (46) . However, the current study revealed no difference of THs between boys with cryptorchidism and those without. Brucker-Davis et al. (10) also reported no difference of THs in cord blood from mothers who gave birth to boys with and without cryptorchidism. However, the results may be very different if a different matrix (i.e., maternal serum, cord blood, infant serum, or placenta) and different TH measurement (i.e., total concentrations or free concentrations) is used. In this study, concentrations of POPs were generally negatively associated with total T 4 and positively associated with total T 3 and total rT 3 concentrations. Previous studies have reported positive (20) (21) (22) , negative (20, 22) , and no associations (19) between certain POP and TH serum concentrations in pregnant women and newborns. However, our results may not be directly comparable to these studies. To our knowledge, only one study exists on THs and brominated flame retardants in placenta; and in that study, placental BDE 99 and BDE 209 levels were negatively associated with rT 3 levels in male infants, whereas BDE 99 and 2,4,6-tribromophenol levels were positively associated with that of T 3 in female infants (26) .
The following mechanisms are involved in the thyroiddisrupting process of POPs: (1) POPs may disrupt the activity of the thyroid gland by interference with the proteins on the thyrocyte; (2) POPs may competitively bind to TH binding proteins [i.e., transthyretin (TTR) and thyroid hormone receptors]; and (3) POPs may affect the peripheral TH metabolism and clearance by interference with the enzymes (47) . Total T 4 in placenta mainly originates from maternal free T 4 , whereas total T 3 and total rT 3 are derived entirely from placental and fetal metabolism of T 4 (48) . Disrupting the TH-protein binding and metabolism in placenta may be of significance. TTR plays a crucial role in transferring free T 4 across the placenta (47) . Binding of certain POPs to TTR may facilitate the transport of these compounds while reducing T 4 delivery to the fetus.
Associations of T 4 with POPs
Our results revealed inverse associations of concentrations of BDEs 47, 99, 100, and SPBDE with that of T 4 , which were in accordance with those of a previous report (26) . The inverse associations could be due to the strong affinities between TTR and BDEs 47, 99, and 100 (49) . PCBs were expected to be associated with T 4 because of their structural resemblance with T 4 . Boas et al. (47) also suggested negative associations between perinatal PCB exposure and THs. However, only negative tendencies toward associations between T 4 and PCBs 99, 118, and 167 were found in this study. This might be due to the differences in the applied matrix and biological indicators of exposure. For example, Majidi et al. (50) analyzed the TH effect of PCBs using standardized concentrations expressed in total PCB equivalent per kilogram of lipids in maternal plasma. The results suggested little evidence for the impact of PCBs on thyroid function in pregnant women and newborns. PCDD/Fs can bind to and activate the aryl hydrocarbon receptor, inducing UDPGT and cytochrome P450 enzymes, which may stimulate the excretion of T 4 (51) . This may explain the inverse association of 2378-TeCDD with T 4 observed in our study. However, we also observed positive associations between concentrations of T 4 and 12378-PeCDD, 1234678-HpCDF, and octachlorodibenzo-pdioxin, probably due to the inhibitory effect of dioxins on the deiodinase activities. DDT (and its metabolite dichlorodiphenyldichloroethylene) and hexachlorobenzene may be associated with THs by interference with the thyroid peroxidase and binding proteins (47) . We observed negative association of T 4 with b-HCH in this study. This might be explained by the similar bioconcentration factor of b-HCH and hexachlorobenzene, which may lead to a similar mechanism of action.
Associations of rT 3 with POPs
rT 3 is an inactive metabolite of T 4 formed by deiodination. Inhibition of deiodinase activities by POPs may lead to reduction in T 4 metabolism, causing lower levels of placental rT 3 (52) . For example, Leonetti et al. (26) reported a negative association between rT 3 and BDE 99 levels among male subjects; this not observed in the current study. We found that TBT, SOTC, b-HCH, and methoxychlor concentrations were inversely associated with that of rT 3 . We also found positive associations between concentrations of rT 3 and PCB 81, 101, 183, 12378-PeCDF, 123478-HxCDF, 123678-HxCDF, 234678-HxCDF, and 1234678-HpCDF, suggesting an alternative mechanism of action. OTCs are a group of chemicals used as biocides in antifouling paints. We observed an association between rT 3 and TBT placental exposure. This association was also found in samples in which TBT concentration was greater than LOQ (b = 21.53; 95% CI, 22.85 to 20.20; P , 0.026). TBT can cross the placenta, inducing physiological and morphological changes that result in abnormal fetal and postnatal development (53) . The findings in current study suggested that in utero exposure of OTCs, especially TBT, is negatively associated with levels of rT 3 .
Associations of T 3 with POPs
Among the 82 POPs investigated, T 3 levels only were positively associated with 2378-TeCDF and 12378-PeCDF levels, and there was a negative tendency toward association with b-HCH levels, suggesting a low sensitivity of T 3 concentration for POP exposures. Placental T 3 is produced by deiodination in the placenta and fetus, whereas T 4 is partly derived from maternal free T 4 . Therefore, the feedback regulation, which is induced by T 3 , may not take place in placenta, and thus maternal pituitary regulation might be out of regulatory function for placental T 3 .
We also estimated the associations of THs with the WHO-TEQ values of PCDD/Fs and PCBs. As shown in an online repository (31) , no significant associations were observed.
Strengths and limitations
This study has several unique strengths: (1) We investigated the thyroid-disrupting effect of as many as 82 POPs, as well as the WHO-TEQ values of PCDD/Fs and PCBs, which provide an overview of the possible relationships between the POPs and THs in placenta; (2) UPLC-Q-TOF-MS was adopted for TH analysis, which provides better accuracy and reliability than immunoassay methods; (3) a wide variety of demographical characteristics were assessed and considered in the statistical analysis. Taking various characteristics into consideration increases the robustness. However, the study also has certain limitations. For example, the number of samples is limited (n = 58), which may reduce the statistical power. Only placenta samples from mothers who gave birth to boys were included in this research, thus we could not reveal any sex-dependent effect. The hydroxylated metabolites of certain POPs (e.g., PCBs and PBDEs), which generally show higher affinities to the TH-binding proteins, were not included in this study. The THs and POPs we measured reflect the situation at delivery instead of gestation. Our previous study suggested that milk analyses might be more reliable toward the lower end of concentrations (33) . Free THs may be more important for analyzing the effects of POP exposures, whereas total concentrations were measured in the current study. In addition, the enzyme activities in placental samples might help to explain the TH-disrupting effects of the POPs.
Finally, with as many as 82 POP congeners, their sums, and three THs, some significant associations may occur by chance. However, in particular, the associations between PBDEs and T 4 appear robust, because all associations were in the same direction and there is a wellknown structure resemblance of PBDEs to T 4 .
Conclusion
In summary, our results suggest that background exposure to POPs is associated with TH levels in placenta. Our results highlight the challenges of assessing effects on thyroid function, especially during pregnancy, due to the complexity of contaminant mixtures and the sensitivity of the thyroid system of the pregnant woman and the fetus. Finally, the results of this study should be interpreted with caution because of the limited number of subjects included in the analysis. The findings should be confirmed with more placenta samples from boys and girls, also including the deiodination enzyme activities and the hydroxylated metabolites of PBDEs and PCBs.
